Jonas D - Search Results

1

Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units.

Jonas D, Biehler K, Hartung D, Spitzmüller B, Daschner FD. Jonas D, et al. Antimicrob Agents Chemother. 2005 Feb;49(2):773-5. doi: 10.1128/AAC.49.2.773-775.2005. Antimicrob Agents Chemother. 2005. PMID: 15673764 Free PMC article.

2

Development and mechanism of fluoroquinolone resistance in Legionella pneumophila.

Jonas D, Engels I, Hartung D, Beyersmann J, Frank U, Daschner FD. Jonas D, et al. J Antimicrob Chemother. 2003 Feb;51(2):275-80. doi: 10.1093/jac/dkg054. J Antimicrob Chemother. 2003. PMID: 12562691

3

Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units.

Meyer E, Schwab F, Jonas D, Rueden H, Gastmeier P, Daschner FD. Meyer E, et al. Among authors: jonas d. Intensive Care Med. 2004 Jun;30(6):1089-96. doi: 10.1007/s00134-004-2266-9. Epub 2004 Mar 26. Intensive Care Med. 2004. PMID: 15045167

4

Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).

Meyer E, Schwab F, Gastmeier P, Jonas D, Rueden H, Daschner FD. Meyer E, et al. Among authors: jonas d. Infect Control Hosp Epidemiol. 2006 Feb;27(2):146-54. doi: 10.1086/500619. Epub 2006 Feb 8. Infect Control Hosp Epidemiol. 2006. PMID: 16465631

5

The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo.

Jonas D, Engels I, Daschner FD, Frank U. Jonas D, et al. J Antimicrob Chemother. 2000 Sep;46(3):385-90. doi: 10.1093/jac/46.3.385. J Antimicrob Chemother. 2000. PMID: 10980164

6

In vitro susceptibility to everninomycin of gram-positive nosocomial pathogens isolated from intensive care units in Germany.

Kropec A, Frank U, Jonas D, Thriene W, Schmidt-Eisenlohr E, Daschner FD. Kropec A, et al. Among authors: jonas d. Chemotherapy. 2001 Jan-Feb;47(1):15-8. doi: 10.1159/000048496. Chemotherapy. 2001. PMID: 11125228

7

Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila.

Jonas D, Engels I, Friedhoff C, Spitzmüller B, Daschner FD, Frank U. Jonas D, et al. J Antimicrob Chemother. 2001 Feb;47(2):147-52. doi: 10.1093/jac/47.2.147. J Antimicrob Chemother. 2001. PMID: 11157897

8

Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI).

Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Meyer E, et al. Among authors: jonas d. Infection. 2003 Aug;31(4):208-15. doi: 10.1007/s15010-003-3201-7. Infection. 2003. PMID: 14562943

9

[Quality assurance in intensive care medicine. SARI-surveillance on antibiotic use and bacterial resistance in intensive care units].

Meyer E, Schroeren-Boersch B, Schwab F, Jonas D, Rüden H, Gastmeier P, Daschner FD. Meyer E, et al. Among authors: jonas d. Anaesthesist. 2004 May;53(5):427-33. doi: 10.1007/s00101-004-0668-2. Anaesthesist. 2004. PMID: 15004690 German.

10

[SARI: surveillance of antibiotic use and bacterial resistance in German intensive care units. Correlation between antibiotic use and the emergence of resistance].

Meyer E, Jonas D, Schwab F, Gastmeier P, Rüden H, Daschner FD. Meyer E, et al. Among authors: jonas d. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Apr;47(4):345-51. doi: 10.1007/s00103-004-0804-9. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004. PMID: 15205777 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters